4.3 Review

Advances in antigens associated with Idiopathic Membranous Nephropathy

Journal

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
Volume 120, Issue 11, Pages 1941-1948

Publisher

ELSEVIER TAIWAN
DOI: 10.1016/j.jfma.2021.06.014

Keywords

Antibodies; Antigens; Glomerulonephritis; Membranous

Funding

  1. National Natural Science Foundation of China [81671596]
  2. National Science Foundation for Young Scientists of China [31700795]
  3. Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties [SZGSP001]
  4. Shenzhen Key Medical Discipline Construction Fund [SZXK059]

Ask authors/readers for more resources

Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, with Idiopathic MN (IMN) being one of its forms and usually having an unknown etiology. IMN is described as an autoimmune disease, and while the exact mechanisms of its occurrence and development are still unclear, the discovery of the M-type phospholipase A(2) receptor (PLA(2)R) has greatly advanced our understanding of IMN. Recent research on target antigens associated with IMN has made considerable progress, providing scientific insight and innovative ideas for future studies.
Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. Idiopathic MN (IMN), one of the forms of MN, usually has an unknown etiology. IMN is described as an auto immune disease, and its pathogenesis is quite complex. The discovery of the M-type phospholipase A(2) receptor (PLA(2)R) plays an important role in promoting our understanding of IMN, although the exact mechanisms of its occurrence and development are still not completely clear. Other target antigens have been discovered one after another, as considerable progress has been made in the molecular pathomechanisms of IMN. Here, we review the findings about the target antigens associated with IMN in recent years. It is hoped that this article can provide researchers with some scientific issues or innovative ideas for future studies of IMN, which will provide clinicians with more knowledge about further improving their abilities to provide better medical care for IMN patients. Copyright (C) 2021, Formosan Medical Association. Published by Elsevier Taiwan LLC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available